Cargando…
Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone‐only pill
INTRODUCTION: Approximately 100 million women currently use combined oral contraceptives. Combined oral contraceptives use is associated with increased risk of venous thromboembolic events and cardiovascular disease. Progestin‐only pills do not increase the risk of venous thromboembolic events, stro...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186823/ https://www.ncbi.nlm.nih.gov/pubmed/31321765 http://dx.doi.org/10.1111/aogs.13688 |